Skip to main content

Table 1 Clinical and demographic data

From: Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

 

HP

N = 24

HTG

N = 31

p

Age (years)

43 ± 11

46 ± 9

NS

Age first onset AP

40 ± 11

-

 

AP Episo N°

2.3 ± 1.9 (1–9)

  

1epis

9 (37.5%)

  

2epis

9 (37.5%)

  

≥ 3 epis

6 (25%)

  

Sex (Men)

21 (90%)

28 (87%)

NS

Smokers

15 (62%)

19 (61%)

NS

Alcohol users

12 (50%)

17 (55%)

NS

AF

13 (54%)

13 (42%)

NS

BMI (kg/m2)

26.5 ± 4.0

29.3 ± 5.0

0.03

<25

10 (42%)

4(13%)

 

25–30

10 (42%)

14 (45%)

 

>30

4 (17%)

13 (42%)

 

Diet only

11 (45%)

8 (26%)

 

Fibrates

13 (54%)

18 (58%)

 

Niacin

1 (4%)

0

NS

Fish oils

0

5 (16%)

 

Statins

1 (4%)

4 (13%)

 

Comorbidities

   

Diabetes

7 (29)

9 (29)

NS

Hypertension

5 (21)

13 (42)

0.052

Fatty Liver

5 (21)

9 (29)

NS

Vascular disease

3 (12)

5 (16)

NS

Coronary artery disease

1 (4)

5 (16)

NS

  1. AP: acute pancreatitis. AF: positive family history.
  2. HP : hypertriglyceridaemic pancreatitis; HTG: severe hypertriglyceridaemia;